All Stories

  1. AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model

    Article • Oncology Reports, September 2016, Spandidos Publications

    Dr Daniel E Gomez

  2. Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models

    Article • Clinical & Experimental Metastasis, May 2016, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  3. RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging

    Article • Cell Death and Disease, October 2015, Nature

    Dr Daniel E Gomez

  4. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

    Article • SpringerPlus, August 2015, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  5. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

    Article • International Journal of Oncology, April 2015, Spandidos Publications

    Dr Daniel E Gomez, Juan Garona

  6. Novel Insights into the Evolution and Structural Characterization of Dyskerin Using Comprehensive Bioinformatics Analysis

    Article • Journal of Proteome Research, January 2015, American Chemical Society (ACS)

    Dr Daniel E Gomez

  7. Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

    Article • OncoTargets and Therapy, October 2014, Taylor & Francis

    Daniel Gomez, Dr Daniel E Gomez

  8. Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2014, Bentham Science Publishers

    Daniel Gomez, Dr Daniel E Gomez

  9. Mechanisms of Cellular Uptake, Intracellular Transportation, and Degradation of CIGB-300, a Tat-Conjugated Peptide, in Tumor Cell Lines

    Article • Molecular Pharmaceutics, April 2014, American Chemical Society (ACS)

    Dr Daniel E Gomez

  10. Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells

    Article • Molecular Medicine Reports, April 2014, Spandidos Publications

    Dr Daniel E Gomez, Juan Garona

  11. Protein universe containing a PUA RNA-binding domain

    Article • FEBS Journal, November 2013, Wiley

    Dr Daniel E Gomez

  12. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

    Article • Breast Cancer Research and Treatment, October 2013, Springer Science + Business Media

    Dr Daniel E Gomez, Juan Garona

  13. Telomerase regulation: A key to inhibition?

    Article • International Journal of Oncology, September 2013, Spandidos Publications

    Dr Daniel E Gomez

  14. Anti-idiotype antibodies in cancer treatment

    Article • Frontiers in Oncology, January 2013, Frontiers

    Dr Daniel E Gomez

  15. Neurogenic differentiation of human adipose-derived stem cells: Relevance of different signaling molecules, transcription factors, and key marker genes

    Article • Gene, December 2012, Elsevier

    Dr Daniel E Gomez

  16. Telomere structure and telomerase in health and disease

    Article • International Journal of Oncology, August 2012, Spandidos Publications

    Dr Daniel E Gomez

  17. The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target

    Article • PLoS ONE, July 2012, PLOS

    Dr Daniel E Gomez, Juan Garona

  18. Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization

    Article • Journal of Peptide Science, March 2012, Wiley

    Dr Daniel E Gomez

  19. AZT as a telomerase inhibitor

    Article • Frontiers in Oncology, January 2012, Frontiers

    Dr Daniel E Gomez

  20. Cancer Antigen Prioritization: A Road Map to Work in Defining Vaccines Against Specific Targets. A Point of View

    Article • Frontiers in Oncology, January 2012, Frontiers

    Dr Daniel E Gomez

  21. Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells

    Article • Future Medicinal Chemistry, December 2011, Future Science

    Dr Daniel E Gomez, Juan Garona

  22. CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

    Article • Molecular and Cellular Biochemistry, July 2011, Springer Science + Business Media

    Dr Daniel E Gomez

  23. CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo

    Article • Experimental Cell Research, July 2011, Elsevier

    Dr Daniel E Gomez

  24. Effect of atorvastatin in a case of feline multicentric lymphoma — Case report

    Article • Acta Veterinaria Hungarica, March 2011, Akademiai Kiado

    Dr Daniel E Gomez

  25. Transcriptional Characterization of Wnt and Notch Signaling Pathways in Neuronal Differentiation of Human Adipose Tissue-Derived Stem Cells

    Article • Journal of Molecular Neuroscience, March 2011, Springer Science + Business Media

    Dr Daniel E Gomez

  26. Effect of Adjuvant Perioperative Desmopressin in Locally Advanced Canine Mammary Carcinoma and its Relation to Histologic Grade

    Article • Journal of the American Animal Hospital Association, January 2011, American Animal Hospital Association

    Dr Daniel E Gomez

  27. Tissue factor as a novel marker for detection of circulating cancer cells

    Article • Biomarkers, December 2010, Taylor & Francis

    Dr Daniel E Gomez

  28. Differential Expression of Shh and BMP Signaling in the Potential Conversion of Human Adipose Tissue Stem Cells Into Neuron-Like Cells In Vitro

    Article • Gene Expression, June 2010, Cognizant Communication Corporation

    Dr Daniel E Gomez

  29. Dietary factors, genetic and epigenetic influences in colorectal cancer

    Article • Experimental and Therapeutic Medicine, January 2010, Spandidos Publications

    Dr Daniel E Gomez

  30. NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

    Article • Developmental Immunology, January 2010, Hindawi Publishing Corporation

    Dr Daniel E Gomez

  31. Contractile Behaviour of Rat Seminal Vesicle after Gonadectomy, Testosterone Replacement and Cyproterone Treatment

    Article • Andrologia, April 2009, Wiley

    Dr Daniel E Gomez

  32. Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

    Article • Journal of Experimental & Clinical Cancer Research, January 2009, Springer Science + Business Media

    Dr Daniel E Gomez

  33. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study

    Article • The Veterinary Journal, October 2008, Elsevier

    Dr Daniel E Gomez

  34. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

    Article • Molecular and Cellular Biochemistry, June 2008, Springer Science + Business Media

    Dr Daniel E Gomez

  35. Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice

    Article • International Journal of Cancer, January 2007, Wiley

    Dr Daniel E Gomez

  36. Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model

    Article • Clinical Cancer Research, December 2006, American Association for Cancer Research (AACR)

    Dr Daniel E Gomez

  37. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice

    Article • Carcinogenesis, April 2004, Oxford University Press (OUP)

    Dr Daniel E Gomez

  38. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer

    Article • Expert Review of Vaccines, December 2003, Taylor & Francis

    Dr Daniel E Gomez

  39. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model

    Article • Journal of Cancer Research and Clinical Oncology, December 2002, Springer Science + Business Media

    Dr Daniel E Gomez

  40. Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation

    Article • Journal of Surgical Oncology, August 2002, Wiley

    Dr Daniel E Gomez

  41. Article • Clinical & Experimental Metastasis, January 2002, Springer Science + Business Media

    Dr Daniel E Gomez

  42. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo

    Article • Melanoma Research, June 2001, Wolters Kluwer Health

    Dr Daniel E Gomez

  43. In Vitro Activity of a Solanum tuberosum Extract against Mammary Carcinoma Cells

    Article • Planta Medica, January 2001, Thieme Publishing Group

    Dr Daniel E Gomez

  44. Chronic In Vitro Exposure to 3′-Azido-2′, 3′-Dideoxythymidine Induces Senescence and Apoptosis and Reduces Tumorigenicity of Metastatic Mouse Mammary Tumor Cells

    Article • Breast Cancer Research and Treatment, January 2001, Springer Science + Business Media

    Dr Daniel E Gomez

  45. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells

    Article • International Journal of Cancer, January 2001, Wiley

    Dr Daniel E Gomez

  46. Antimetastatic effect of desmopressin in a mouse mammary tumor model

    Article • Breast Cancer Research and Treatment, October 1999, Springer Science + Business Media

    Dr Daniel E Gomez

  47. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype

    Article • FEBS Journal, July 1999, Wiley

    Dr Daniel E Gomez

  48. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

    Article • Breast Cancer Research and Treatment, July 1998, Springer Science + Business Media

    Dr Daniel E Gomez

  49. Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) Treatment

    Article • Biochemical and Biophysical Research Communications, May 1998, Elsevier

    Dr Daniel E Gomez

  50. Ulex Europaeus I Lectin Induces Activation of Matrix-Metalloproteinase-2 in Endothelial Cells

    Article • Biochemical and Biophysical Research Communications, November 1995, Elsevier

    Dr Daniel E Gomez

  51. Partial Characterization of Novel Serine Proteinase Inhibitors from Human Umbilical Vein Endothelial Cells

    Article • Archives of Biochemistry and Biophysics, May 1995, Elsevier

    Dr Daniel E Gomez

  52. Thrombin treatment of endothelial cells stimulates adhesion of oncogene transformed but not parent rat liver epithelial cells

    Article • Thrombosis Research, April 1995, Elsevier

    Dr Daniel E Gomez

  53. Expression and Characterization of Human Tissue Inhibitor of Metalloproteinases-1 in a Baculovirus-Insect Cell System

    Article • Biochemical and Biophysical Research Communications, August 1994, Elsevier

    Dr Daniel E Gomez

  54. Effect of Host-Organ Environment on the in vivo and in vitro Behavior of a Murine Mammary Adenocarcinoma

    Article • Tumor Biology, January 1994, Springer Science + Business Media

    Dr Daniel E Gomez

  55. Tumor invasion, proteolysis, and angiogenesis

    Article • Journal of Neuro-Oncology, January 1994, Springer Science + Business Media

    Dr Daniel E Gomez

  56. Immunomagnetic separation as a final purification step of liver endothelial cells

    Article • In Vitro Cellular & Developmental Biology - Animal, June 1993, Springer Science + Business Media

    Dr Daniel E Gomez

  57. Expression of gelatinise/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion

    Article • Clinical & Experimental Metastasis, May 1992, Springer Science + Business Media

    Dr Daniel E Gomez

  58. In vivo selection and characterization of a murine mammary tumor subline with high potential for spontaneous lymph node metastasis

    Article • Journal of Surgical Oncology, November 1990, Wiley

    Dr Daniel E Gomez

  59. Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotype

    Article • Biochemical and Biophysical Research Communications, August 1988, Elsevier

    Dr Daniel E Gomez